In silico Platform for designing genome-based
Personalized immunotherapy or Vaccine against Cancer

Predicted Immune Epitope Results

The result page of search shows exclusive peptide/epitopes generated due to mutation [Neoepitope], the tissue of origin [Tissue], position of peptide in protein [Position], number of mismatches counted by aligning mutated and normal protein sequence [Num Mismatch, percentage of cell lines with this peptide over total number of cell lines [Promiscuity %]. The immune information include CTL epitopes (Yes/No), MHC I binders, MHC II binders (both given as number of alleles) and B cell epitopes (Yes/No). For more information, please click HERE

NeoepitopesLQPDIQQLY        Click here to BLAST against human proteome
CTL Epitope
HLA I Alleles
(ProPred I)
HLA-B*2702, HLA-B*2705, HLA-B*3501, HLA-B*3701, HLA-B*4403, HLA-B*51, HLA-B*5301, HLA-B62, HLA-Cw*0702, MHC-Dd10
HLA I Alleles
HLA II Alleles
DRB1_0301, DRB1_0306, DRB1_0307, DRB1_0308, DRB1_0309, DRB1_0311, DRB1_11077

CANCERTOPE    |     Raghava's Group    |     IMTECH    |     CSIR    |     CRDD    |     GPSR Package